Olivier Lada
Boulogne-billancourt, 92100, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database.
Journal: Psychiatry research
Published: December 02, 2023
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).
Journal: The Lancet regional health. Europe
Published: December 24, 2021
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.
Journal: Journal of clinical microbiology
Published: January 13, 2015
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 31, 2014
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
Journal: PloS one
Published: October 17, 2014
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 12, 2014
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Journal: Antimicrobial agents and chemotherapy
Published: July 02, 2014
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.
Journal: Journal of virology
Published: March 28, 2014
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: June 04, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Journal: Journal of viral hepatitis
Published: May 01, 2013
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.
Journal: Journal of hepatology
Published: August 10, 2012
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Journal: Antiviral therapy
Published: January 24, 2012
Last Updated: 09/26/2026